NorthCoast Asset Management LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1665198
STAMFORD, CT
Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,576,001
+$2,991,113 QoQ
Shares Held
5,735
+657.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#428
of 1,329 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NorthCoast Asset Management LLC holds $60,121,102 across 7 Biotechnology names. REGN ranks #3 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,246 | $47,311,545 | |
| 2 | INCY |
Incyte Corp
|
37,421 | $4,242,044 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
5,735 | $3,576,001 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
33,137 | $1,896,099 | |
| 5 | DRTS |
Alpha Tau Medical Ltd.
|
135,017 | $1,698,513 | |
| 6 | EXEL |
Exelixis, Inc.
|
14,885 | $809,892 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,950 | $587,008 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,576,001 | 5,735 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $584,888 | 757 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $588,164 | 762 | Shares | Sole | 2026-02-20 | |
| 2025-09-30 | $739,947 | 1,316 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $677,250 | 1,290 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,394,579 | 6,929 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $1,976,715 | 2,775 | Shares | Sole | 2025-08-25 | |
| 2024-09-30 | $3,880,126 | 3,691 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $2,509,859 | 2,388 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $955,752 | 993 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $210,789 | 240 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $219,730 | 267 | Shares | Sole | 2023-11-09 | |
| 2023-03-31 | $235,819 | 287 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $228,712 | 317 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,408,739 | 2,045 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,531,026 | 2,590 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,065,227 | 2,957 | Shares | Sole | 2022-04-22 | |
| 2021-09-30 | $2,197,408 | 3,631 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,203,440 | 3,945 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $595,210 | 1,258 | Shares | Sole | 2021-05-06 | |
| 2020-03-31 | $1,189,962 | 2,437 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||